| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/27/2004 | CA2505797A1 Process for converting a cis-trans mixture of substituted benzylidene amines into the pure cis isomer |
| 05/27/2004 | CA2505127A1 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | CA2502190A1 Pyrimidine compounds |
| 05/26/2004 | EP1422553A1 Improved base precursors for use in a photothermographic element |
| 05/26/2004 | EP1422224A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 05/26/2004 | EP1422218A1 Antiviral agent |
| 05/26/2004 | EP1421389A2 Neurofibrillary labels |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421078A1 Beta-3 adrenergic agonists |
| 05/26/2004 | EP1421074A1 Novel compounds |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421063A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
| 05/26/2004 | EP1420780A2 Cyclopropyl and cyclobutyl epothilone analogs |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1173176B1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 05/26/2004 | EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP1022272B1 Substituted fused heterocyclic compounds |
| 05/26/2004 | EP0968194B1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 05/26/2004 | CN1500086A Aminopiperidine derivatives |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500080A 稠合杂环化合物 Fused heterocyclic compounds |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151147C Indole derivatives as 5-HT receptor antagonist |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/25/2004 | CA2302058C A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041816A1 Azacyclic compounds as orexin receptor antagonist |
| 05/21/2004 | WO2004041815A1 Indole derivative with 5ht1a affinity |
| 05/21/2004 | WO2004041813A1 Compositions useful as inhibitors of rock and other protein kinases |
| 05/21/2004 | WO2004041809A2 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
| 05/21/2004 | WO2004041808A1 4-imidazol-1-ylmethyl-pyrimidine derivatives_as ligands for gabaa receptors |
| 05/21/2004 | WO2004041799A1 5- (substituted phenyl) -thiadiazolidine-3-ones and their use as ptp1b |
| 05/21/2004 | WO2004041795A1 Novel inhibitors of dipeptidyl peptidase iv |
| 05/21/2004 | WO2004041794A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 05/21/2004 | WO2004041793A1 Phenylalkyl and pyridylalkyl piperazine derivatives |
| 05/21/2004 | WO2004041782A1 Indoles useful in the treatment of androgen-receptor related diseases |
| 05/21/2004 | WO2004041777A2 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041776A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041279A1 Gamma-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041277A1 Carbonylamino-benzimidazole derivatives as androgen receptor modulators |
| 05/21/2004 | WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | WO2004041164A2 Kinase inhibitors |
| 05/21/2004 | WO2004041163A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004026226A8 Compounds, compositions and methods |
| 05/21/2004 | WO2004014860A3 Fused heterocyclic compounds as peptidase inhibitors |
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | CA2505397A1 Phenylalkyl and pyridylalkyl piperazine derivatives |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/21/2004 | CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | CA2504320A1 Compositions useful as inhibitors of rock and other protein kinases |
| 05/21/2004 | CA2504044A1 Carbonylamino-benzimidazole derivatives as androgen receptor modulators |
| 05/21/2004 | CA2503720A1 Gamma-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | CA2503715A1 Kinase inhibitors |
| 05/21/2004 | CA2503713A1 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2502178A1 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2495708A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 05/21/2004 | CA2484936A1 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
| 05/20/2004 | US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 05/20/2004 | US20040097732 Peptide deformylase inhibitors |
| 05/20/2004 | US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 05/20/2004 | US20040097729 Substituted pyridine herbicides |
| 05/20/2004 | US20040097728 Method for producing anellated tetrahydro-{1h}-triazoles |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097579 Taxane formulations |
| 05/20/2004 | US20040097574 For therapy of inflammatory, allergic, or proliferative processes |
| 05/20/2004 | US20040097571 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/20/2004 | US20040097566 For therapy of diseases related to uncontrolled cellular proliferation, useful for modulating lipid and/or carbohydrate metabolism, for therapy of Type II diabetes, hyperglycemia or obesity, inflammatory diseases such as arthritis |
| 05/20/2004 | US20040097564 Method and compounds for treating glaucoma VI |
| 05/20/2004 | US20040097560 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 05/20/2004 | US20040097559 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 05/20/2004 | US20040097558 Hetaryl substituted homotetramic and homtetronic acids and the use thereof as pesticides |
| 05/20/2004 | US20040097555 Useful as a prophylactic or therapeutic agent of the diseases such as rheumatism, arthritis and the like, and other diseases |
| 05/20/2004 | US20040097553 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| 05/20/2004 | US20040097545 Quinolinone derivatives |
| 05/20/2004 | US20040097531 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |
| 05/20/2004 | US20040097513 Novel non-imidazole compounds |
| 05/20/2004 | US20040097503 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097496 Novel thiazine derivatives |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097492 For inhibiting hepatitis C virus (HCV) polymerase; therapy and prophylaxis of HCV infection |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |